• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bioavailability and efficacy of a sustained-release theophylline tablet.

作者信息

Mitenko P A, Ogilvie R I

出版信息

Clin Pharmacol Ther. 1974 Oct;16(4):720-6. doi: 10.1002/cpt1974164720.

DOI:10.1002/cpt1974164720
PMID:4609343
Abstract
摘要

相似文献

1
Bioavailability and efficacy of a sustained-release theophylline tablet.一种缓释茶碱片的生物利用度和疗效
Clin Pharmacol Ther. 1974 Oct;16(4):720-6. doi: 10.1002/cpt1974164720.
2
Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.食物对缓释茶碱片生物利用度及释放模式的影响。
J Clin Pharmacol. 1982 Apr;22(4):196-200. doi: 10.1002/j.1552-4604.1982.tb02162.x.
3
Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.哮喘患儿从静脉注射茶碱转换为缓释口服茶碱的情况。
Drug Intell Clin Pharm. 1986 Sep;20(9):700-3. doi: 10.1177/106002808602000916.
4
Evaluation of a new sustained-release theophylline tablet for children.一种新型儿童用缓释茶碱片的评估
Acta Paediatr Scand. 1981 Nov;70(6):929-33. doi: 10.1111/j.1651-2227.1981.tb06253.x.
5
Relative bioavailability of two sustained-release theophylline formulations versus an immediate-release preparation.两种茶碱缓释制剂与速释制剂的相对生物利用度。
J Asthma. 1983;20(1):27-30. doi: 10.3109/02770908309070908.
6
The relation of product formulation to absorption of oral theophylline.产品配方与口服茶碱吸收的关系。
N Engl J Med. 1978 Oct 19;299(16):852-7. doi: 10.1056/NEJM197810192991603.
7
Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.多次口服缓释茶碱片制剂后，茶碱在比格犬和哮喘患者体内的药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1986 Oct;24(10):528-35.
8
Rational intravenous doses of theophylline.氨茶碱的合理静脉给药剂量。
N Engl J Med. 1973 Sep 20;289(12):600-3. doi: 10.1056/NEJM197309202891202.
9
Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.哮喘儿童持续治疗期间，缓释型茶碱制剂的吸收情况不一致。
J Pediatr. 1985 Mar;106(3):496-501. doi: 10.1016/s0022-3476(85)80690-9.
10
A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.一种缓释茶碱制剂：对血清茶碱水平低的儿童哮喘的疗效。
Ann Allergy. 1978 Apr;40(4):252-7.

引用本文的文献

1
Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.住院患者口服缓释氨茶碱：与毒性和血浆茶碱浓度相关的因素
Br J Clin Pharmacol. 1980 Aug;10(2):101-7. doi: 10.1111/j.1365-2125.1980.tb01725.x.
2
Components of variability in serum theophylline concentrations during maintenance therapy with a sustained release formulation.维持治疗期间使用缓释制剂时血清茶碱浓度的变异性组成部分。
Eur J Clin Pharmacol. 1982;23(3):225-8. doi: 10.1007/BF00547558.
3
Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
茶碱缓释片餐后给药时生物利用度大幅提高。
Eur J Clin Pharmacol. 1983;24(6):761-7. doi: 10.1007/BF00607084.
4
In vitro testing of controlled release theophylline preparations: Theolair, Theograd and Theolin.
Pharm Weekbl Sci. 1983 Apr 29;5(2):65-9. doi: 10.1007/BF01960078.
5
Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.茶碱普通无包衣剂型和缓释剂型的生物利用度及药代动力学与吸烟习惯的关系。I. 单剂量研究。
Eur J Clin Pharmacol. 1983;24(1):79-87. doi: 10.1007/BF00613931.
6
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.缓释型茶碱产品选用的临床及药代动力学依据
Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001.
7
New method for bioavailability assessment of slow-release preparations of theophylline.
J Pharmacokinet Biopharm. 1985 Dec;13(6):571-87. doi: 10.1007/BF01058902.
8
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.对人类研究中终末半衰期、原形药物排泄百分比以及肾功能和肝功能不全时半衰期变化进行批判性汇编，并列出参考文献。
J Pharmacokinet Biopharm. 1975 Oct;3(5):333-83. doi: 10.1007/BF01082306.
9
The efficacy of Neo-Biphyllin Retard in asthmatic patients--a theophylline slow-releasing coated tablet.新必林缓释片（一种茶碱缓释包衣片）在哮喘患者中的疗效。
Pneumonologie. 1976 Jun 25;153(3):177-84. doi: 10.1007/BF02095883.
10
Clinical pharmacokinetics of theophylline.茶碱的临床药代动力学
Clin Pharmacokinet. 1978 Jul-Aug;3(4):267-93. doi: 10.2165/00003088-197803040-00002.